Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Business

Dr Lal PathLabs to acquire 70 pc stake in SN Genelab for Rs 168 crore

New Delhi: Diagnostic services provider Dr Lal PathLabs Ltd on Thursday said its board of directors has approved a 70 per cent stake acquisition in Gujarat-based SN Genelab for about Rs 168 crore.

The transaction also includes a performance-linked earn-out capped at Rs 31.5 crore, the company said in a regulatory filing.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.